TB-500 explained

TB-500 is a research peptide often discussed alongside BPC-157. This overview explains what it is structurally and how it is handled in the lab. It is written for in-vitro research and makes no therapeutic or dosing claims.

Relationship to thymosin beta-4

TB-500 is commonly described as corresponding to an active region of thymosin beta-4, a naturally occurring protein. In research materials, TB-500 refers to a synthetic peptide based on that region rather than the full-length protein — a distinction worth noting when comparing literature.

Why it is studied

TB-500 features in preclinical and in-vitro work involving cell-motility and tissue models. As with any research peptide, the findings live in the studies; this page does not extend them to any human context.

Handling notes

• Supplied lyophilised; reconstitute by running solvent down the vial wall, never by shaking.
• Keep the dry solid sealed, cold and dark.
• Refrigerate after reconstitution and aliquot for repeated use.

For in-vitro research use only. Not for human or veterinary use.